Track topics on Twitter Track topics that are important to you
This event is drawing attendance from active medtech investors, strategic buyers and the innovators building the future of healthcare.
Christopher J. Velis, Chairman of Miraki Innovation and Co-Founder of Auris Health (acquired by J&J for $5.7B) will deliver the keynote address at the Life Science Intelligence (LSI) Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA.
In his keynote, “The Next Quantum Leaps in Medtech,” Velis will share his insights on a repeatable process for quantum leaps of innovation. He’ll discuss his experiences building companies such as Auris Health and he’ll provide both an investor's and innovator's perspective on the future of medtech.
In addition to Velis’ keynote, the event will include over 100 startup CEO presentations, and lively panel discussions with venture capitalists, large corporates, and industry thought leaders.
A full agenda and list of attendees is here.
Investors attending include: JJDC, Sante Ventures, Connecticut Innovations, US Venture Partners, NEA, Pangaea Ventures, SV Health Investors, Miraki Innovation Fund, MVM Partners, Evonik VC, Sands Capital, Mayo Clinic Ventures, HealthTech Capital, Grey Sky Venture Partners, and more.
Strategics attending include: J&J, Medtronic, Boston Scientific, Abbott, Stryker, Edwards Lifesciences, Terumo, Fresenius, Intuitive Surgical, BD, W.L. Gore, and more.
About Life Science Intelligence (LSI)
LSI is a medical technology focused market intelligence & consulting company. We help medtech executives make informed strategic decisions by better understanding market dynamics, trends, opportunities and the competitive landscape.
Life Science Intelligence
714 847 3540 Tel
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...